gogogo
Syndetics cover image
Image from Syndetics

The analysis of controlled substances / Michael D. Cole.

By: Material type: TextTextSeries: Analytical techniques in the sciencesPublication details: New York : Wiley, c2003.Description: xvi, 196 p. : ill. (some col.) ; 24 cmISBN:
  • 0471492531 (pbk. : alk. paper)
Subject(s): DDC classification:
  • 615.78 COL
Online resources:
Holdings
Item type Current library Call number Copy number Status Date due Barcode
Standard Loan Moylish Library Main Collection 615.78 COL (Browse shelf(Opens below)) 1 Available 39002100320333

Enhanced descriptions from Syndetics:

Presenting new developments in sampling and drug profiling, this book also provides practical information on how to carry out analysis, what the results mean and how they can be used as court evidence and for drugs intelligence purposes.

* Includes case-studies with full data and spectra, helping readers to identify substances
* Accessibly organized by class of compound
* Contains an up-to-date list of the newest drugs

Includes bibliographical references and index.

Table of contents provided by Syndetics

  • Series Preface (p. xi)
  • Preface (p. xiii)
  • Acronyms, Abbreviations and Symbols (p. xv)
  • About the Author (p. xvii)
  • 1 Introduction to Drug Trends, Control, Legislation and Analysis (p. 1)
  • 1.1 Introductory Remarks (p. 1)
  • 1.2 International Legislation (p. 2)
  • 1.3 Controlled Substances in the United Kingdom (p. 3)
  • 1.3.1 Background to the Misuse of Drugs Act, 1971 (p. 3)
  • 1.3.2 The Provisions of the Misuse of Drugs Act, 1971 (p. 3)
  • 1.4 Controlled Substances in the United States (p. 5)
  • 1.5 Controlled Substances in Australia (p. 5)
  • 1.6 The Drug Chemist and Drug Analysis (p. 5)
  • 1.7 Quality Assurance in the Drugs Laboratory (p. 9)
  • 1.8 Presentation of Evidence in Court (p. 10)
  • References (p. 11)
  • 2 Amphetamine and Related Compounds (p. 13)
  • 2.1 Introduction (p. 13)
  • 2.2 Qualitative Identification of Amphetamines (p. 15)
  • 2.2.1 Sampling and Physical Description of Amphetamines (p. 15)
  • 2.2.2 Presumptive Testing of Amphetamines (p. 18)
  • 2.2.3 Thin Layer Chromatography of Amphetamines (p. 19)
  • 2.2.4 Definitive Identification of Amphetamines (p. 20)
  • 2.3 Quantification of Amphetamines (p. 25)
  • 2.4 Comparison and Profiling of Amphetamine Samples (p. 31)
  • 2.4.1 The Leuckart Synthesis of Amphetamine (p. 32)
  • 2.4.2 The Reductive Amination of Benzyl Methyl Ketone (p. 32)
  • 2.4.3 The Nitrostyrene Synthesis (p. 33)
  • 2.4.4 Impurity Extraction and Sample Comparison (p. 34)
  • References (p. 36)
  • 3 The Analysis of LSD (p. 37)
  • 3.1 Introduction (p. 37)
  • 3.2 Qualitative Identification of LSD (p. 38)
  • 3.2.1 Sampling and Physical Description of LSD Blotter Acid (p. 39)
  • 3.2.2 Extraction of LSD Prior to Analysis (p. 41)
  • 3.2.3 Presumptive Testing for LSD (p. 42)
  • 3.2.4 Thin Layer Chromatography of Samples Containing LSD (p. 43)
  • 3.2.5 Confirmatory Tests for the Presence of LSD (p. 43)
  • References (p. 47)
  • 4 Cannabis sativa and Products (p. 49)
  • 4.1 Introduction (p. 49)
  • 4.2 Origins, Sources and Manufacture of Cannabis (p. 51)
  • 4.3 Analytical Sequence, Bulk and Trace Sampling Procedures (p. 53)
  • 4.4 Qualitative Identification of Cannabis (p. 54)
  • 4.4.1 Identification of Herbal Material (p. 55)
  • 4.4.2 Identification of Other Materials (p. 57)
  • 4.4.3 Comparison of Cannabis Samples (p. 65)
  • References (p. 72)
  • 5 Diamorphine and Heroin (p. 73)
  • 5.1 Introduction (p. 73)
  • 5.2 Origins, Sources and Manufacture of Diamorphine (p. 74)
  • 5.3 Appearance of Heroin and Associated Paraphernalia (p. 77)
  • 5.4 Bulk and Trace Sampling Procedures (p. 78)
  • 5.5 Identification, Quantification and Comparison of Heroin Samples (p. 79)
  • 5.5.1 Presumptive Tests for Heroin (p. 80)
  • 5.5.2 Thin Layer Chromatography of Heroin Samples (p. 81)
  • 5.5.3 Gas Chromatographic--Mass Spectroscopic Identification of Heroin (p. 83)
  • 5.5.4 Quantification of Heroin Samples (p. 87)
  • 5.5.5 Comparison of Heroin Samples (p. 87)
  • References (p. 95)
  • 6 Cocaine (p. 97)
  • 6.1 Introduction (p. 97)
  • 6.2 Origins, Sources and Manufacture of Cocaine (p. 99)
  • 6.2.1 Extraction and Preparation of Coca Paste (p. 99)
  • 6.2.2 Synthesis of Pure Cocaine (p. 100)
  • 6.3 Qualitative Identification of Cocaine (p. 100)
  • 6.3.1 Presumptive Tests for Cocaine (p. 100)
  • 6.3.2 Thin Layer Chromatography (p. 102)
  • 6.3.3 Definitive Identification of Cocaine (p. 103)
  • 6.4 Quantification of Cocaine (p. 107)
  • 6.4.1 Quantification of Cocaine by GC-MS (p. 107)
  • 6.4.2 Quantification of Cocaine by UV Spectroscopy (p. 108)
  • 6.5 Comparison of Cocaine Samples (p. 109)
  • References (p. 110)
  • 7 Products from Catha edulis and Lophophora williamsii (p. 113)
  • 7.1 Introduction (p. 113)
  • 7.2 Products of Catha edulis (p. 113)
  • 7.2.1 Identification, Quantification and Comparison of Khat Samples (p. 115)
  • 7.2.2 Comparison of Khat Samples (p. 119)
  • 7.3 Products of Lophophora williamsii (p. 119)
  • 7.3.1 Physical Description and Sampling of Materials (p. 120)
  • 7.3.2 Presumptive Tests for Mescaline (p. 121)
  • 7.3.3 TLC Analysis of Mescaline (p. 121)
  • 7.3.4 HPLC Analysis of Mescaline (p. 122)
  • 7.3.5 GC-MS Analysis of Mescaline (p. 124)
  • 7.3.6 Comparison of Peyote Samples (p. 124)
  • References (p. 125)
  • 8 The Analysis of Psilocybin and Psilocin from Fungi (p. 127)
  • 8.1 Introduction (p. 127)
  • 8.2 Identification of Psilocybin- and Psilocin-Containing Mushrooms (p. 129)
  • 8.2.1 Identification of Fungal Species from Morphological Characteristics (p. 129)
  • 8.2.2 Identification of Psilocin and Psilocybin Using Chemical Analysis (p. 130)
  • 8.2.3 Quantification of Psilocin and Psilocybin by HPLC (p. 135)
  • 8.3 The Identification of Psilocybin- and Psilocin-Containing Fungi Using DNA Profiling (p. 136)
  • References (p. 137)
  • 9 The Analysis of Controlled Pharmaceutical Drugs--Barbiturates and Benzodiazepines (p. 139)
  • 9.1 Introduction (p. 139)
  • 9.2 Analysis of Barbiturates and Benzodiazepines (p. 141)
  • 9.2.1 Extraction of Barbiturates and Benzodiazepines from Dose Forms (p. 142)
  • 9.2.2 Presumptive Tests for Barbiturates and Benzodiazepines (p. 142)
  • 9.2.3 TLC of Barbiturates and Benzodiazepines (p. 143)
  • 9.2.4 Confirmatory Analysis of Barbiturates and Benzodiazepines (p. 146)
  • 9.2.5 Quantification of Barbiturates and Benzodiazepines (p. 149)
  • References (p. 151)
  • 10 Current Status, Summary and Conclusions (p. 153)
  • 10.1 Current Status of Drug Analysis (p. 153)
  • 10.2 Conclusions (p. 155)
  • Appendices (p. 157)
  • 1 Presumptive (Colour) Tests (p. 157)
  • 2 Less-Common Controlled Substances (p. 159)
  • Responses to Self-Assessment Questions (p. 161)
  • Bibliography (p. 175)
  • Glossary of Terms (p. 179)
  • SI Units and Physical Constants (p. 183)
  • Periodic Table (p. 187)
  • Index (p. 189)

Author notes provided by Syndetics

Michael D. Cole is the author of The Analysis of Controlled Substances , published by Wiley.

Powered by Koha